China AI Technology Export Registration

Overview

The Ministry of Commerce (MOFCOM) and Ministry of Science and Technology (MOST) issued Joint Announcement No. 48 of 2026 on 16 October 2026. It combines consultation on revising the Catalogue of Technologies Prohibited and Restricted from Export from China with mandatory temporary pre-export registration. The proposed additions cover 40 technologies: 23 artificial-intelligence technologies, five biopharmaceutical technologies and 12 photovoltaic technologies. The official announcement identifies the Foreign Trade Law and Regulations on the Administration of Technology Import and Export as its legal basis. Annex 1 supplies proposed technical coverage and policy explanations.

The components have different statuses. The catalogue amendment is expressly a consultation draft, with comments invited from 16 October through 15 November 2026; its proposed prohibitions and restrictions are not made effective by this announcement. Section III's temporary registration requirement, however, applies from publication, including to exports already started but not completed. It continues until the catalogue is formally revised and implemented, not merely until consultation closes. No subsequent implementation date or termination is identified in the cited materials. Registration uses MOFCOM's technology trade management application. No registration approval period is specified, and registration is not described as an export licence.

Definitions

The announcement identifies technology areas and transaction triggers rather than providing a comprehensive technical glossary. AI coverage concerns large models, agents, computing clusters and information processing. Biopharmaceutical coverage concerns cell and gene therapy, small nucleic-acid drugs and pathogenic microorganisms. Photovoltaic coverage concerns polysilicon, silicon-wafer and cell manufacturing, including key and core equipment carrying the relevant technology. These subject areas are not exhaustive classification tests: businesses must compare their technology with Annex 1 rather than assume every AI model, biomedical process or photovoltaic product is covered. No parameter-count threshold or exhaustive definition of a large model is supplied in the announcement body.

Section III(2) identifies overseas transfers of technology ownership, including intellectual-property assignments; authorisation of overseas use of domestic technology, including intellectual-property licensing; and changes making a domestic technology's owner or actual controller an overseas entity. Other situations may be expressly designated by MOFCOM through notices or similar instruments. Actual control has no specified ownership-percentage threshold or exhaustive test. Relevant AI technologies already in the public domain through open-source release, academic publication or comparable means are excluded from the management scope. A planned open-source release should not automatically be treated as technology already in the public domain. Automatic licensing is a distinct proposed facilitation mechanism, not temporary registration.

Governance and Institutional Framework

MOFCOM and MOST jointly issue the announcement and propose the revision. MOFCOM's Security and Control Bureau is identified as the publishing office and recipient of postal consultation submissions. The MOFCOM unified business system platform hosts the technology trade management information application used for registration. The duty rests on technology export operators, not solely foreign recipients or intermediaries; the announcement gives no separate exhaustive definition of an operator. Application requirements govern the information entered, with Annex 2 providing the technology export information registration form. The announcement creates no AI-specific regulator, certification body or international supervisory institution.

Consultation may address technological scope, indicators, control policies and facilitation measures. The official MOFCOM explanation describes earlier engagement with research institutions, industry organisations and major enterprises. It asks exporters to assess coverage and says businesses encountering registration difficulties may consult MOFCOM and MOST. These explanations do not replace annex-based classification or mandatory filing. No provincial delegation structure, interagency dispute-resolution process or dedicated procedure for binding advance classification decisions is specified.

Key Focus Areas

The AI component concerns cross-border transfers of selected technologies, not general regulation of domestic AI development, deployment or consumer-facing services. Its 23 proposed entries span large models, agents, computing clusters and information processing, subject to the public-domain exclusion. The official explanation links the initiative to preventing misuse and uncontrolled technology diffusion while supporting international cooperation, and discusses deployment and service models in the context of future catalogue treatment. Such explanations must not be converted into either an immediate blanket AI export prohibition or a blanket exemption from registration for overseas AI business arrangements.

The five proposed biopharmaceutical entries concern cell and gene therapy, small nucleic-acid drugs and pathogenic microorganisms. The proposed policy design provides automatic licensing and other facilitation for outward licensing arrangements without ownership transfer. The 12 photovoltaic entries concern polysilicon, wafers and cells and include relevant key and core technology-bearing equipment. The announcement does not impose identical treatment on every product in these industries. Proposed restricted classification, facilitation, public-domain exclusion and temporary registration are separate concepts requiring assessment against the announcement and relevant annex criteria. Proposed automatic licensing must not be confused with the immediately applicable registration process.

Implementation Framework

Section III(1) requires operators to register before exporting technologies listed in the annex and expressly includes exports already begun but unfinished. Section III(3) identifies exporter and recipient information, destination country or region, intended technology and use, and estimated export value as principal filing categories. The application's current requirements control, and Annex 2 supplies the form. The announcement specifies no minimum monetary threshold, grace period for unfinished exports or fixed number of days before export for filing. Its list of information should not be treated as exhaustive where the application requires additional fields.

Multiple technologies intended for one export to the same recipient may be registered together; other circumstances should, in principle, be entered separately. An internal process connecting classification, recipient identification, transaction structure and filing preparation before export is a compliance recommendation, not an independently prescribed governance duty. Operators should verify current platform fields and assess other applicable obligations separately. Registration is not stated to grant an export licence, authorise a prohibited transaction or replace authorisations under other instruments. The full contents and direct attachment URLs of Annexes 1 and 2 are not reproduced in the official material available for this entry; complete technical criteria and form fields therefore cannot be independently enumerated here.

Monitoring and Evaluation

Temporary registration collects transaction-level information on parties, technology, intended use, destination and anticipated value before export, including for unfinished transactions. The official explanation identifies understanding export demand, improving scientific administration and preventing potential export risks as its objectives. This is administrative monitoring, not technical model evaluation. The announcement imposes no AI benchmark testing, safety evaluation, conformity testing, red-teaming, post-market incident reporting, periodic performance assessment or recurring annual reporting requirement.

Consultation provides a separate channel for evaluating and refining the proposed technical scope, indicators, controls and facilitation arrangements. The official explanation anticipates dynamic catalogue adjustment as technologies develop, but the announcement sets no periodic review cycle, mandatory publication date for consultation results or timetable for resolving individual comments. Retaining classification reasoning and filing details is an internal safeguard, not an express record-retention obligation; no retention period is specified. Operators should monitor platform updates and later official notices because the application controls filing information and MOFCOM may expressly designate additional registration situations.

Penalties, Liability, and Appeals

Registration is mandatory during the temporary period, but the announcement contains no dedicated schedule of administrative fines, criminal offences, confiscation measures or civil compensation rules. It provides no export-value penalty calculation or separate sanction for incorrectly combining filings. Citation of the Foreign Trade Law and technology import/export regulations does not, by itself, establish the precise sanction for a particular breach. Enforcement analysis requires examination of applicable provisions and transaction circumstances rather than importing sanctions from unrelated export-control measures. The absence of announcement-specific sanctions does not make registration voluntary.

No dedicated administrative reconsideration procedure, appeal deadline, court jurisdiction rule, review body, formal classification appeal, registration refusal process or guaranteed response period is stated. Businesses may consult MOFCOM and MOST about difficulties, but that consultation is not described as a statutory appeal or automatic suspension of obligations. Compliance practice should resolve uncertainty before completing a potentially covered export and distinguish technical scope questions from filing-system problems. If an administrative decision is made, available general remedies require separate legal assessment. No announcement-specific processing or record-retention period is identified.

Relationship to Other Instruments

The announcement operates alongside the existing export technology catalogue and rests on the Foreign Trade Law and Regulations on the Administration of Technology Import and Export. Annex 1, expressly labelled a consultation draft, describes the proposed AI, biopharmaceutical and photovoltaic scope and policy treatment. Annex 2 supports the immediate registration process. They have different functions and should not be presented as standalone legislative acts. Publication does not bring the proposed catalogue additions into force, while the draft status of those additions does not postpone Section III's registration obligation.

The temporary measure ends when the catalogue is formally revised and implemented; no fixed date is supplied. Existing legal requirements must be assessed independently because registration does not replace an existing licence or other authorisation. Official explanations of future deployment and licensing treatment provide interpretive context, but the announcement and annex conditions remain central to classification. No repeal, supersession or mutual-recognition relationship with an overseas AI law is established. The cited materials identify neither a subsequent catalogue implementation date nor a termination of temporary registration.

International Alignment

Cross-border relevance follows from overseas ownership transfers, overseas use of domestic technology, and changes making an overseas entity the owner or actual controller. Destination country or region is a required registration category. The announcement names no targeted foreign country and establishes neither destination-specific prohibitions nor reciprocity based on foreign AI rules. The official explanation characterises the revision as routine technology trade administration, not action against a particular country, region or entity, and presents necessary controls as consistent with international practice while supporting normal technological exchange and cooperation.

International cooperation does not automatically exempt a transaction from temporary registration. The proposed design includes the AI public-domain exclusion and facilitation for certain biopharmaceutical licences without ownership transfer. Additional cooperative settings discussed in the official explanation depend on future catalogue rules and annex conditions. No treaty obligation, international certification system or recognition of foreign export authorisations is created. Companies should assess Chinese transaction-based requirements and independently applicable foreign rules. General cooperation objectives do not establish compliance with international trade agreements or equivalence with another jurisdiction's export-control regime.

Implementation Timeline

Sources and References